Coverage Update on Prevnar and Pneumovax Pneumococcal Vaccines

As seen in the Consultant Connection February 2015 Issue
As indicated in the October 2014 Consultant Connection, both forms of pneumococcal vaccine, Prevnar and Pneumovax, should be routinely administered in series to all adults 65 years or older. This recommendation from the CDC’s Advisory Committee on Immunization Practices is now also reflected in new payment guidelines from CMS. Medicare B now covers one dose of each vaccine, as long as the time interval between the two vaccinations is at least 11 months.
There are more than 90 strains (serotypes) of pneumococcal bacteria.  Prevnar and Pneumovax cover 13 and 23 of these serotypes, respectively. Complete recommendations may be found at: